Symbol
| BRD9
| contributors: mct/npt - updated : 16-12-2020
|
HGNC name
| bromodomain containing 9
|
HGNC id
| 25818
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
| amplification
|  
|  
|
in early stages of non-small cell lung cancer (Kang 2008) | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
cancer | hemopathy | | |
as a potential therapeutic target for leukemia | cancer | | | |
potential therapeutic target to promote synthetic lethality and overcome chemoresistance | cancer | | | |
BRD9 inhibitors may show utility in preventing epigenetically-defined drug resistance |
| | | |